TNF and bacterial infectious disease: Approaches to enhance host immunity and for reducing bacterial infection such as adenoviral gene therapy for over production of IL-2, using TNF-α pro-inflammatory cytokine and cyclic di-GMP have shown promise in boosting immunity and reduced bacterial infections.